{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:06:07Z","timestamp":1794002767408,"version":"4.8.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T00:00:00Z","timestamp":1582329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Egypt Natl Canc Inst"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Hepatic complications are a well-known cause of both early and late mortality and morbidity in hematopoietic stem cell transplant (HSCT) recipients. Early diagnosis and management of hepatic complications is important in order to commence appropriate therapy. Conditioning regimens, acute and chronic graft versus host disease, sinusoidal obstruction syndrome, and infections among others represent major hepatic complications for the transplant recipient. We assessed liver function tests, viral markers, polymerase chain reaction, abdominal ultrasound, portal, and hepatic venous duplex in 88 patients underwent autologous and 102 patients underwent allogeneic transplant as well as liver biopsy in selected patients in this retrospective study and evaluated early and late hepatic complications and their impact on transplant outcome.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The major cause of hepatic injury in allogeneic patients is the conditioning regimen (38.8%) followed by acute GVHD (14.7%), after day +100 chronic hepatic GVHD is the primary cause of liver injury which occurred in about 40% of allogeneic patients. In autologous patients, the first cause of hepatotoxicity is also conditioning regimen involving 27.9% of patients followed by flare of viral hepatitis in 7.9% and sepsis in 6.3% of cases. The prevalence of HCV, HBV, and CMV is 19%, 16%, and 8%, respectively.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>In our study, conditioning regimens, acute and chronic hepatic GVHD are frequent causes of hepatic injury following allogeneic HSCT while conditioning regimens, flare of viral hepatitis, and sepsis represent the most common causes of hepatic injury following autologous HSCT.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s43046-020-0020-1","type":"journal-article","created":{"date-parts":[[2020,2,22]],"date-time":"2020-02-22T14:02:39Z","timestamp":1582380159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Liver disease during and after hematopoietic stem cell transplantation in adults: a single-center Egyptian experience"],"prefix":"10.1186","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0962-9289","authenticated-orcid":false,"given":"Haitham","family":"Abdelbary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Magdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Moussa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inas","family":"Abdelmoaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,22]]},"reference":[{"issue":"4","key":"20_CR1","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3324\/haematol.2016.150250","volume":"102","author":"Y Inamoto","year":"2017","unstructured":"Inamoto Y, Lee S. Late effects of blood and marrow transplantation. Haematologica. 2017;102(4):614\u201325.","journal-title":"Haematologica."},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.bmt.1702453","volume":"26","author":"BK Kim","year":"2000","unstructured":"Kim BK, Chung KW, Sun HS, Suh JG, Min WS, Kang CS, et al. Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study. Bone Marrow Transplant. 2000;26:193\u20137.","journal-title":"Bone Marrow Transplant."},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.bbmt.2011.04.009","volume":"17","author":"P Barba","year":"2011","unstructured":"Barba P, Pi\u00f1ana JL, Fern\u00e1ndez-Avil\u00e9s F, Perez-Sim\u00f3n JA, Martino R, L\u00f3pez-Guerrro E, et al. Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: A study of 455 patients. Biol Blood Marrow Transplant. 2011;17:1653\u201361.","journal-title":"Biol Blood Marrow Transplant."},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912\u20139.","journal-title":"Blood."},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.7326\/0003-4819-144-6-200603210-00007","volume":"144","author":"T Parimon","year":"2006","unstructured":"Parimon T, Au DH, Martin PJ, Chien JW. A risk score for mortality after allogeneic hematopoietic cell transplantation. Ann Intern Med. 2006;144:407\u201314.","journal-title":"Ann Intern Med."},{"key":"20_CR6","first-page":"111","volume":"25","author":"M Arat","year":"2008","unstructured":"Arat M, Idilman R. Hepatic complications of allogeneic hematopoietic cell transplantation. Turk J hematol. 2008;25:111\u201323.","journal-title":"Turk J hematol."},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1440-1746.1995.tb01039.x","volume":"10","author":"G Forbes","year":"1995","unstructured":"Forbes G, Davies J, Herrmann R, Collins BJ. Liver disease complicating bone marrow transplantation: a clinical audit. J Gastroenterol Hepatol. 1995;10:1\u20137.","journal-title":"J Gastroenterol Hepatol."},{"issue":"12","key":"20_CR8","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1097\/00042737-200412000-00019","volume":"16","author":"MH El-Sayed","year":"2004","unstructured":"El-Sayed MH, El-Haddad A, Fahmy OA, Salama I, Mahmoud HK. Liver disease is a major cause of mortality following allogeneic bone marrow transplantation. Eur J Gastroenterol Hepatol. 2004;16(12):1347\u201354.","journal-title":"Eur J Gastroenterol Hepatol."},{"issue":"2","key":"20_CR9","first-page":"99","volume":"53","author":"J Zhao","year":"2014","unstructured":"Zhao J, Ren H, Qui Z, Wang M, Liu W, Xu W, et al. The influence of liver dysfunction before transplantation and during conditioning period on the outcome of allogeneic hematopoietic stem cell transplantation. Zhonghua Nei Ke Za Zhi. 2014;53(2):99\u2013103.","journal-title":"Zhonghua Nei Ke Za Zhi."},{"issue":"4","key":"20_CR10","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/bmt.2016.302","volume":"52","author":"G Battipaglia","year":"2017","unstructured":"Battipaglia G, Labopin M, Candoni A, Fanin R, El Cheikh J, Blaise D, et al. Risk of sinusoidal obstruction syndrome in allogeneic stem cell transplantation after prior gemtuzumab ozogamicin treatment: a retrospective study from the acute leukemia working party of the EBMT. Bone Marrow Transplant. 2017;52(4):592\u20139.","journal-title":"Bone Marrow Transplant."},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1053\/jhep.2000.8438","volume":"32","author":"F Abdel-Aziz","year":"2000","unstructured":"Abdel-Aziz F, Habib M, Mohamed M, Abdel-Hamid M, Gamil F, Madkour S, et al. Hepatitis C virus infection in a community in the nile delta:population description and HCV prevalence. Hepatology. 2000;32:111\u20135.","journal-title":"Hepatology."},{"issue":"11","key":"20_CR12","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1182\/blood-2016-05-718643","volume":"128","author":"HA Torres","year":"2016","unstructured":"Torres HA, McDonald GB. How I treat hepatitis C virus infection in patients with hematologic malignancies. Blood. 2016;128(11):1449\u201357.","journal-title":"Blood."},{"issue":"5","key":"20_CR13","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/rmv.322","volume":"11","author":"L Xunorong","year":"2001","unstructured":"Xunorong L, Yan A, Liang R, Lau GK. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy-- pathogenesis and management. Rev Med Virol. 2001;11(5):287\u201399.","journal-title":"Rev Med Virol."},{"issue":"1","key":"20_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1182\/asheducation-2006.1.375","volume":"2006","author":"Roberto J. Firpi","year":"2006","unstructured":"Firpi RJ, Nelson DR. Viral hepatitis: manifestations and management strategy. Hematology Am Soc Hematol Educ Program. 2006:375\u201380.","journal-title":"Hematology"},{"issue":"1","key":"20_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s00277-016-2831-7","volume":"96","author":"K Piukovics","year":"2017","unstructured":"Piukovics K, Terhes G, Gurbity-P\u00e1lfi T, Bereczki A, R\u00e1rosi F, De\u00e1k J, et al. Cytomegalovirus infection in patients with hematological diseases and after autologus stem cell transplantation as consolidation: A single center study. Ann Hematol. 2017;96(1):125\u201331.","journal-title":"Ann Hematol."},{"issue":"3","key":"20_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/tid.12542","volume":"18","author":"E Panagou","year":"2016","unstructured":"Panagou E, Zakout G, Keshani J, Smith C, Irish D, Mackinnon S, et al. Cytomegalovirus pre-emptive therapy after hematopoietic stem cell transplantation in the era of real-time quantitative PCR: comparison of recipients of solid organ transplants. Transpl Infect Dis. 2016;18(3):405\u201314.","journal-title":"Transpl Infect Dis."},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-3-662-44000-1_4","volume-title":"Infections in hematology","author":"M Nucci","year":"2015","unstructured":"Nucci M, Anaissie E. Infections after high-dose chemotherapy and autologus hematopoietic stem cell transplantation. In: Maschmeyer G, Rolston KV, editors. Infections in hematology. 1st ed. Heidelberg: Springer-Verlag Berlin Heidelberg; 2015. p. 49\u201361.","edition":"1"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-020-0020-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s43046-020-0020-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s43046-020-0020-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,21]],"date-time":"2021-02-21T02:31:47Z","timestamp":1613874707000},"score":1,"resource":{"primary":{"URL":"https:\/\/jenci.springeropen.com\/articles\/10.1186\/s43046-020-0020-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,22]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1186\/s43046-020-0020-1","relation":{},"ISSN":["2589-0409"],"issn-type":[{"value":"2589-0409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,22]]},"assertion":[{"value":"7 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed written consent was obtained from all participants. The study was conducted in accordance with the stipulations of the local ethical and scientific committees of Ain Shams University and the procedures respected the ethical standards in the Helsinki Declaration of 1964. No ethics committee reference number was provided, instead, a stamped approval was given.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}